Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer

Aberrant activation of Wnts is common in human cancers, including prostate. Hypermethylation associated transcriptional silencing of Wnt antagonist genes SFRPs (Secreted Frizzled-Related Proteins) is a frequent oncogenic event. The significance of this is not known in prostate cancer. The objectives of our study were to (i) profile Wnt signaling related gene expression and (ii) investigate methylation of Wnt antagonist genes in prostate cancer. Using TaqMan Low Density Arrays, we identified 15 Wnt signaling related genes with significantly altered expression in prostate cancer; the majority of which were upregulated in tumors. Notably, histologically benign tissue from men with prostate cancer appeared more similar to tumor (r = 0.76) than to benign prostatic hyperplasia (BPH; r = 0.57, p < 0.001). Overall, the expression profile was highly similar between tumors of high (≥ 7) and low (≤ 6) Gleason scores. Pharmacological demethylation of PC-3 cells with 5-Aza-CdR reactivated 39 genes (≥ 2-fold); 40% of which inhibit Wnt signaling. Methylation frequencies in prostate cancer were 10% (2/20) (SFRP1), 64.86% (48/74) (SFRP2), 0% (0/20) (SFRP4) and 60% (12/20) (SFRP5). SFRP2 methylation was detected at significantly lower frequencies in high-grade prostatic intraepithelial neoplasia (HGPIN; 30%, (6/20), p = 0.0096), tumor adjacent benign areas (8.82%, (7/69), p < 0.0001) and BPH (11.43% (4/35), p < 0.0001). The quantitative level of SFRP2 methylation (normalized index of methylation) was also significantly higher in tumors (116) than in the other samples (HGPIN = 7.45, HB = 0.47, and BPH = 0.12). We show that SFRP2 hypermethylation is a common event in prostate cancer. SFRP2 methylation in combination with other epigenetic markers may be a useful biomarker of prostate cancer.

IGFBP7 promoter methylation and gene expression analysis in prostate cancer

PURPOSE: IGFBP7 belongs to a family of insulin-like growth factor-1 regulatory binding proteins. IGFBP7 hypermethylation is associated with its down-regulation in various carcinomas. In prostate cancer IGFBP7 down-regulation has been widely reported but to our knowledge the mechanisms behind this event are unknown. We performed a denaturing high performance liquid chromatography screening and validation strategy to profile the methylation status of IGFBP7 in prostate cancer.

MATERIALS AND METHODS: We combined denaturing high performance liquid chromatography and bisulfite sequencing to examine IGFBP7 methylation in a panel of prostate cancer cell lines. Quantitative methylation specific polymerase chain reaction was used to determine methylation levels in prostate tissue specimens of primary prostate cancer, histologically benign prostate adjacent to tumor, high grade prostatic intraepithelial neoplasia and benign prostatic hyperplasia. IGFBP7 gene expression was measured by quantitative methylation specific polymerase chain reaction in cell lines and tissue specimens.

RESULTS: IGFBP7 was methylated in the 4 prostate cancer cell lines DU145, LNCaP, PC-3 and 22RV1. Quantitative methylation specific polymerase chain reaction analysis revealed that promoter methylation was associated with decreased IGFBP7 expression. Quantitative methylation specific polymerase chain reaction showed that IGFBP7 methylation was more frequently detected in prostate cancer (60% (31/52)) and high grade prostatic intraepithelial neoplasia (40% (6/15)) samples compared to histologically benign prostate adjacent to tumor (10%) and benign prostatic hyperplasia (0%) samples.

CONCLUSIONS: To our knowledge this is the first report of aberrant IGFBP7 promoter hypermethylation and concurrent IGFBP7 gene silencing in prostate cancer cell lines. Results demonstrate that CpG methylation of IGFBP7 may represent a novel biomarker of prostate cancer and pre-invasive neoplasms. Thus, future examination of IGFBP7 methylation and expression in a larger patient cohort, including bodily fluids, is justified to further evaluate its role in a diagnostic and prognostic setting.

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia:a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring

Wilms' tumor gene 1 (WT1) is overexpressed in the majority (70-90%) of acute leukemias and has been identified as an independent adverse prognostic factor, a convenient minimal residual disease (MRD) marker and potential therapeutic target in acute leukemia. We examined WT1 expression patterns in childhood acute lymphoblastic leukemia (ALL), where its clinical implication remains unclear. Using a real-time quantitative PCR designed according to Europe Against Cancer Program recommendations, we evaluated WT1 expression in 125 consecutively enrolled patients with childhood ALL (106 BCP-ALL, 19 T-ALL) and compared it with physiologic WT1 expression in normal and regenerating bone marrow (BM). In childhood B-cell precursor (BCP)-ALL, we detected a wide range of WT1 levels (5 logs) with a median WT1 expression close to that of normal BM. WT1 expression in childhood T-ALL was significantly higher than in BCP-ALL (P<0.001). Patients with MLL-AF4 translocation showed high WT1 overexpression (P<0.01) compared to patients with other or no chromosomal aberrations. Older children (> or =10 years) expressed higher WT1 levels than children under 10 years of age (P<0.001), while there was no difference in WT1 expression in patients with peripheral blood leukocyte count (WBC) > or =50 x 10(9)/l and lower. Analysis of relapsed cases (14/125) indicated that an abnormal increase or decrease in WT1 expression was associated with a significantly increased risk of relapse (P=0.0006), and this prognostic impact of WT1 was independent of other main risk factors (P=0.0012). In summary, our study suggests that WT1 expression in childhood ALL is very variable and much lower than in AML or adult ALL. WT1, thus, will not be a useful marker for MRD detection in childhood ALL, however, it does represent a potential independent risk factor in childhood ALL. Interestingly, a proportion of childhood ALL patients express WT1 at levels below the normal physiological BM WT1 expression, and this reduced WT1 expression appears to be associated with a higher risk of relapse.

A miR-433 mediated mechanism of chemoresistance in high grade serous ovarian cancer (HGSOC).

Higher expression of the miR-433 microRNA (miRNA) is associated with poorer survival outcomes in patients with HGSOC that may be overcome by a greater understanding of the functional role of this miRNA. We previously described miR-433 as a critical cell cycle regulator and mediator of cellular senescence. Downregulation of the mitotic arrest deficiency 2 (MAD2) protein by miR-433 led to increased cellular resistance to paclitaxel in epithelial ovarian cancer cells (EOC). Furthermore immunohistochemical (IHC) analysis of MAD2 expression in patients with HGSOC showed that loss of MAD2 was significantly associated with poorer patient survival. Higher miR-433 expression is also associated with an increased resistance to the platins which is unrelated to loss of MAD2 expression. In silico analysis of the miR-433 target proteins in the TCGA database identified the association between a number of miR-433 targets and poorer patient survival. IHC analysis of the miR-433 target, histone deacetylase 6 (HDAC6), confirmed that its expression was significantly associated with a decrease in patient overall survival. The knock-down of HDAC6 by siRNA in EOC cells did not attenuate apoptotic responses to paclitaxel or platin although lower endogenous HDAC6 expression was associated with more resistant EOC cell lines. In vitro analysis revealed that EOC cells which survived chemotherapeutic kill with high doses of paclitaxel expressed higher miR-433 and concomitant decreased expression of the miR-433 targets. These cells were more chemoresistant compared to the parental cell line and repopulated as 3d organoid cultures in non-adherent stem cell selective conditions; thus indicating that the cells which survive chemotherapy were viable, capable of regrowth and had an increased potential for pluripotency. In conclusion, our data suggests that chemotherapy is not driving the transcriptional upregulation of miR-433 but rather selecting a population of cells with high miR-433 expression that may contribute to chemoresistant disease and tumour recurrence.

Alterations in beta-catenin expression and localization in prostate cancer

BACKGROUND: Wnt signaling is thought to be important in prostate cancer, in part because proteins such as beta-catenin can also affect androgen receptor signaling. beta-Catenin forms a cell adhesion complex with E-cadherin raising the possibility that loss of expression or a change in beta-catenin distribution in the cell could also alter downstream signaling, decreased inter-cellular adhesion and the promotion of metastasis. A number of studies have reported the altered expression and/or localization of beta-catenin as a biomarker in prostate cancer.

METHODS: Tissue microarrays comprised of BPH and low, moderate and high-grade prostate cancer (n=77) were assessed for beta-catenin expression and distribution using immunohistochemistry. Staining was also performed on a tissue microarray containing tissue from patients before and after hormone manipulation. The effects of fixation and different antibodies was assessed on fixed LNCaP cell pellets and small prostate tissue microarrays.

RESULTS: We have observed increased beta-catenin expression in only high Gleason score (>7) prostate cancer. A nuclear re-distribution of beta-catenin has previously been reported. We noted nuclear beta-catenin in benign prostatic hyperplasia and a gradual loss in nuclear distribution with increasing Gleason grade. We found no evidence for an alteration in beta-catenin expression or re-distribution with hormone ablation. Altered fixation, antibodies and antibody concentration did affect the intensity and specificity of staining.

CONCLUSIONS: A loss of nuclear beta-catenin is the most consistent feature in prostate cancer rather than absolute levels of expression. We also suggest that variation in immunohistochemical protocols may explain variations in the reported literature.

A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression

Aberrant activation of Wnt/β-catenin signaling, resulting in the expression of Wnt-regulated oncogenes, is recognized as a critical factor in the etiology of colorectal cancer. Occupancy of β-catenin at promoters of Wnt target genes drives transcription, but the mechanism of β-catenin action remains poorly understood. Here, we show that CARM1 (coactivator-associated arginine methyltransferase 1) interacts with β-catenin and positively modulates β-catenin-mediated gene expression. In colorectal cancer cells with constitutively high Wnt/β-catenin activity, depletion of CARM1 inhibits expression of endogenous Wnt/β-catenin target genes and suppresses clonal survival and anchorage-independent growth. We also identified a colorectal cancer cell line (RKO) with a low basal level of β-catenin, which is dramatically elevated by treatment with Wnt3a. Wnt3a also increased the expression of a subset of endogenous Wnt target genes, and CARM1 was required for the Wnt-induced expression of these target genes and the accompanying dimethylation of arginine 17 of histone H3. Depletion of β-catenin from RKO cells diminished the Wnt-induced occupancy of CARM1 on a Wnt target gene, indicating that CARM1 is recruited to Wnt target genes through its interaction with β-catenin and contributes to transcriptional activation by mediating events (including histone H3 methylation) that are downstream from the actions of β-catenin. Therefore, CARM1 is an important positive modulator of Wnt/β-catenin transcription and neoplastic transformation, and may thereby represent a novel target for therapeutic intervention in cancers involving aberrantly activated Wnt/β-catenin signaling.

STAT3 regulated ARF expression suppresses prostate cancer metastasis

Prostate cancer (PCa) is the most prevalent cancer in men. Hyperactive STAT3 is thought to be oncogenic in PCa. However, targeting of the IL-6/STAT3 axis in PCa patients has failed to provide therapeutic benefit. Here we show that genetic inactivation of Stat3 or IL-6 signalling in a Pten-deficient PCa mouse model accelerates cancer progression leading to metastasis. Mechanistically, we identify p19(ARF) as a direct Stat3 target. Loss of Stat3 signalling disrupts the ARF-Mdm2-p53 tumour suppressor axis bypassing senescence. Strikingly, we also identify STAT3 and CDKN2A mutations in primary human PCa. STAT3 and CDKN2A deletions co-occurred with high frequency in PCa metastases. In accordance, loss of STAT3 and p14(ARF) expression in patient tumours correlates with increased risk of disease recurrence and metastatic PCa. Thus, STAT3 and ARF may be prognostic markers to stratify high from low risk PCa patients. Our findings challenge the current discussion on therapeutic benefit or risk of IL-6/STAT3 inhibition.

EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

PURPOSE: EphA2, a member of the Eph receptor tyrosine kinases family, is an important regulator of tumor initiation, neovascularization, and metastasis in a wide range of epithelial and mesenchymal cancers; however, its role in colorectal cancer recurrence and progression is unclear.

EXPERIMENTAL DESIGN: EphA2 expression was determined by immunohistochemistry in stage II/III colorectal tumors (N = 338), and findings correlated with clinical outcome. The correlation between EphA2 expression and stem cell markers CD44 and Lgr5 was examined. The role of EphA2 in migration/invasion was assessed using a panel of KRAS wild-type (WT) and mutant (MT) parental and invasive colorectal cancer cell line models.

RESULTS: Colorectal tumors displayed significantly higher expression levels of EphA2 compared with matched normal tissue, which positively correlated with high CD44 and Lgr5 expression levels. Moreover, high EphA2 mRNA and protein expression were found to be associated with poor overall survival in stage II/III colorectal cancer tissues, in both univariate and multivariate analyses. Preclinically, we found that EphA2 was highly expressed in KRASMT colorectal cancer cells and that EphA2 levels are regulated by the KRAS-driven MAPK and RalGDS-RalA pathways. Moreover, EphA2 levels were elevated in several invasive daughter cell lines, and downregulation of EphA2 using RNAi or recombinant EFNA1 suppressed migration and invasion of KRASMT colorectal cancer cells.

CONCLUSIONS: These data show that EpHA2 is a poor prognostic marker in stage II/III colorectal cancer, which may be due to its ability to promote cell migration and invasion, providing support for the further investigation of EphA2 as a novel prognostic biomarker and therapeutic target. Clin Cancer Res; 22(1); 230-42. ©2015 AACR.

Effects of sucrose on opioid gene expression in the rat brain.

Opioid peptide neurotransmitters stimulate feeding and are involved in mediating the rewarding aspects of feeding, as well as in energy regulation in the brain. The effects of sucrose diets on opioid peptide gene expression were measured in the arcuate nucleus (ARC) and the paraventricular nucleus (PVN) of the rat. Rats were fed a cornstarch-based diet or a low (16.7%), medium (33.4%), or high (50%) sucrose containing diet for 7 days. Analyses of the ARC and PVN demonstrated that sucrose in the diet had no effect on mRNA levels of opioid peptides. The lack of an opioid response in the ARC and PVN suggests that opioids in the ARC and PVN are involved in energy regulation rather than in mediating hedonic aspects of feeding.

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways

BACKGROUND: In spite of the recent discovery of genetic mutations in most myelodysplasic (MDS) patients, the pathophysiology of these disorders still remains poorly understood, and only few in vivo models are available to help unravel the disease.

METHODS: We performed global specific gene expression profiling and functional pathway analysis in purified Sca1+ cells of two MDS transgenic mouse models that mimic human high-risk MDS (HR-MDS) and acute myeloid leukemia (AML) post MDS, with NRASD12 and BCL2 transgenes under the control of different promoters MRP8NRASD12/tethBCL-2 or MRP8[NRASD12/hBCL-2], respectively.

RESULTS: Analysis of dysregulated genes that were unique to the diseased HR-MDS and AML post MDS mice and not their founder mice pointed first to pathways that had previously been reported in MDS patients, including DNA replication/damage/repair, cell cycle, apoptosis, immune responses, and canonical Wnt pathways, further validating these models at the gene expression level. Interestingly, pathways not previously reported in MDS were discovered. These included dysregulated genes of noncanonical Wnt pathways and energy and lipid metabolisms. These dysregulated genes were not only confirmed in a different independent set of BM and spleen Sca1+ cells from the MDS mice but also in MDS CD34+ BM patient samples.

CONCLUSIONS: These two MDS models may thus provide useful preclinical models to target pathways previously identified in MDS patients and to unravel novel pathways highlighted by this study.

Immune-derived PD-L1 gene expression defines a subgroup of stage II/III colorectal cancer patients with favorable prognosis that may be harmed by adjuvant chemotherapy

A recent phase 2 study of metastatic colorectal carcinoma (CRC) patients showed that mismatch repair gene status was predictive of clinical response to PD-1-targeting immune checkpoint blockade. Further examination revealed strong correlation between PD-L1 protein expression and microsatellite instability (MSI) in stage IV CRC, suggesting that the amount of PD-L1 protein expression could identify late stage patients who may benefit from immunotherapy. To assess whether the clinical associations between PD-L1 gene expression and MSI identified in metastatic CRC are also present in stage II/III CRC, we used in silico analysis to elucidate the cell types expressing the PD-L1 gene. We found a significant association of PD-L1 gene expression with MSI in early stage CRC (P < 0.001) and show that unlike in non-CRC tumors, PD-L1 is derived predominantly from the immune infiltrate. We demonstrate that PD-L1 gene expression has positive prognostic value in the adjuvant disease setting (PD-L1low v PD-L1high HR = 9.09; CI, 2.11-39.10). PD-L1 gene expression had predictive value, as patients with high PD-L1 expression appear to be harmed by standard-of-care treatment (HR = 4.95; CI,1.10-22.35). Building on the promising results from the metastatic CRC PD-1-targeting trial, we provide compelling evidence that PD-L1high/MSI/immunehigh stage II/III CRC patients should not receive standard chemotherapy. This conclusion supports the rationale to clinically evaluate this patient subgroup for PD-1 blockade treatment.

Determinant factors for the use of imposex in TBT pollution monitoring

Os compostos de tributilestanho (TBT) foram utilizados como biocidas em tintas antivegetativas (AV) e amplamente aplicados, durante décadas, de forma a evitar a bioincrustação em superfícies submersas, principalmente em cascos de embarcações. Os seus efeitos deletérios em organismos não-alvo tornaram-se evidentes após o aparecimento de gastrópodes prosobrâquios com imposex – sobreposição de caracteres sexuais masculinos sobre o tracto reprodutivo das fêmeas. Desde então, a expressão do imposex em prosobrânquios tem sido amplamente utilizada como biomarcador da poluição por TBT. Um dos objectivos da presente tese é avaliar se as mais recentes restrições legais na utilização das tintas AV com compostos organoestânicos (OTs) resultaram numa redução da poluição pelos mesmos na costa continental Portuguesa. Para tal, foi levada a cabo a análise da variação temporal do imposex como biomarcador dos níveis ambientais de TBT e a validação de procedimentos, de modo a seguir de forma precisa a evolução da intensidade deste fenómeno ao longo do tempo. O trabalho de investigação teve início no momento em que a ineficácia da legislação anterior (Directiva 89/677/CEE) na redução da poluição por TBT no litoral Português era reportada na literatura e quando estavam já agendados instrumentos decisivos para a diminuição definitiva deste tipo de poluição: o Regulamento (CE) N.º 782/2003 do Parlamento e do Conselho da União Europeia (UE) que bania as tintas AV baseadas em TBT na sua frota a partir de 1 de Julho de 2003; a "Convenção Internacional sobre o Controlo de Sistemas Antivegetativos Nocivos em Navios” (Convenção AFS), adoptada em 2001 pela Organização Marítima Internacional (OMI), que procurava erradicar os OTs da frota mundial até 2008. Os níveis de imposex e as concentrações de OTs nos tecidos de fêmeas de Nucella lapillus foram medidos em 17 locais de amostragem ao longo da costa Portuguesa em 2003, a fim de se avaliarem os impactos do TBT nas populações desta espécie e de se criar uma base de dados para seguir a sua evolução futura. O índice da sequência do vaso deferente (VDSI), o índice do tamanho relativo do pénis (RPSI) e a percentagem de fêmeas afectadas por imposex (%I) foram utilizados na medição da intensidade deste fenómeno em cada local de amostragem e os seus valores variaram entre 0,20-4,04, 0,0- 42,2% e 16,7-100,0%, respectivamente. Foram encontradas fêmeas estéreis em 3 locais de amostragem, com percentagens a variar entre 4,0 e 6,2%. As concentrações de TBT e dibutilestanho (DBT) nas fêmeas variaram respectivamente entre 23-138 e <10-62 ng Sn.g-1 de peso seco, e o conteúdo em TBT nos tecidos revelou-se significativamente correlacionado com o imposex (nomeadamente com o RPSI e o VDSI). Os níveis de expressão do fenómeno e o conteúdo em OTs nos tecidos, foram superiores na proximidade de portos, confirmando as conclusões obtidas anteriormente por outros autores de que os navios e a actividade dos estaleiros são as principais fontes destes compostos no litoral Português. As infra-estruturas associadas ás principais fontes de OTs – portos, estaleiros e marinas – estão geralmente localizadas no interior de estuários, motivo pelo qual estas áreas têm vindo a ser descritas como as mais afectadas por estes poluentes. Por esta razão, foi levado a cabo o estudo pormenorizado da poluição por TBT na Ria de Aveiro, como caso de estudo representativo da poluição por estes compostos num sistema estuarino em Portugal continental. N. lapillus foi usada como bioindicador para avaliar a tendência temporal da poluição por TBT nesta área entre 1997 e 2007. Foi registada uma diminuição da intensidade do imposex após 2003, embora as melhorias mais evidentes tenham sido observadas entre 2005 e 2007, provavelmente devido à implementação do Regulamento (CE) N.º 782/2003 que proibiu a aplicação de tintas AV com TBT em navios com a bandeira da UE. Apesar desses progressos, as análises ao conteúdo em OTs nos tecidos de fêmeas de N. lapillus e em amostras de água colhidas em 2006 indicaram contaminação recente por TBT na área de estudo, evidenciando assim a permanência de fontes de poluição. A utilização de N. lapillus como bioindicador da poluição por TBT na Ria de Aveiro apresenta algumas limitações uma vez que a espécie não ocorre nas áreas mais interiores da Ria e não vive em contacto com sedimentos. Assim, a informação obtida a partir da sua utilização como bioindicador é fundamentalmente relativa aos níveis de TBT na coluna de água. Foi então necessário recorrer a um bioindicador complementar – Hydrobia ulvae – para melhor avaliar a evolução temporal da poluição por TBT no interior deste sistema estuarino e estudar a persistência de TBT nos sedimentos. Não foi registada uma diminuição dos níveis de imposex em H. ulvae na Ria de Aveiro entre 1998 e 2007, apesar da aplicação do Regulamento (CE) N.º 782/2003. Pelo contrário, houve um aumento global significativo da percentagem de fêmeas afectadas por imposex e um ligeiro aumento do VDSI, contrastando com o que tem sido descrito para outros bioindicadores na Ria de Aveiro no mesmo período. Estes resultados mostram que a diferente biologia/ecologia das espécies indicadoras determina vias distintas de acumulação de TBT, apontando a importância da escolha do bioindicador dependendo do compartimento a ser monitorizado (sedimento versus água). A ingestão de sedimento como hábito alimentar em H. ulvae foi discutida como sendo a razão para a escolha da espécie como indicadora da contaminação dos sedimentos por TBT. Foram também estudados os métodos mais fiáveis para reduzir a influência de variáveis críticas na medição dos níveis de imposex em H. ulvae. As comparações de parâmetros do imposex baseados em medições do pénis devem ser sempre realizadas sob condições de narcotização bem standardizadas uma vez que este procedimento provoca um aumento significativo do comprimento do pénis (PL) em ambos os sexos. O VDSI, a % e o PL em ambos os sexos revelaram ser fortemente influenciados pelo tamanho dos espécimes: a utilização de fêmeas mais pequenas conduz à subestimação do VDSI, da %I e do PL, enquanto que diferenças no tamanho dos machos provocam variações no índice do comprimento relativo do pénis (RPLI), independentemente dos níveis de poluição por TBT. Existe, portanto, a necessidade de controlar algumas variáveis envolvidas na análise do imposex que mostraram afectar a fiabilidade dos resultados. Uma vez que N. lapillus é o principal bioindicador dos efeitos biológicos específicos do TBT para a área da OSPAR, foi também estudada a influência de algumas variáveis na avaliação dos níveis de imposex nesta espécie, especificamente as relacionadas com o ciclo reprodutor e o tamanho dos espécimes. O estudo do ciclo reprodutor e a variação sazonal/espacial do comprimento do pénis do macho (MPL) incidiu num único local no litoral Português (Areão – região de Aveiro) de forma a avaliar se o RPSI varia sazonal e espacialmente na mesma estação de amostragem e se tais variações influenciam os resultados obtidos em programas de monitorização do imposex. Nos meses de Dezembro de 2005 a Junho de 2007, foram encontrados espécimes de N. lapillus sexualmente maturos e potencialmente aptos para a reprodução. Contudo, foi também evidente um padrão sazonal do ciclo reprodutor – o estado de desenvolvimento da gametogénese nas fêmeas variou sazonalmente e ocorreu uma diminuição do volume da glândula da cápsula e do factor de condição no final do Verão / início do Outono. Contrariamente, a gametogénese nos machos não apresentou variação sazonal significativa, embora os valores mais baixos do factor de condição, do comprimento do pénis e dos volumes de esperma e da próstata tenham também sido registados no final do Verão / início do Outono. Além disso, o MPL mostrou variar, no mesmo local de amostragem, inversamente com a distância aos ninhos de cápsulas ovígeras; um aumento dos valores do MPL foi também observado em espécimes de maior tamanho. Todas estas variações no MPL introduzem desvios nos resultados da avaliação do imposex quando é usado o RPSI. A magnitude do erro envolvido foi quantificada e revelou-se superior em locais com níveis mais elevados de poluição por TBT. Apesar do RPSI ser um índice que fornece informação importante sobre os níveis de poluição por TBT, a sua interpretação deve ser cuidadosa e realizada complementarmente com os outros índices, destacando-se o VDSI como índice mais fiável e com significado biológico mais expressivo. Novas campanhas de monitorização do imposex em N. lapillus foram realizadas ao longo da costa Portuguesa em 2006 e 2008, e os resultados subsequentemente comparados com a base de dados criada em 2003,de forma a avaliar a evolução da poluição por TBT no litoral Português naquele período. Nestes estudos foram aplicados novos procedimentos na monitorização e tratamento dos dados, de forma a minimizar a variação nos índices de avaliação do imposex induzida pelos factores acima descritos, para seguir com maior consistência a tendência da poluição por TBT entre 2003 e 2008. Foi observado um declínio global significativo na intensidade de imposex na área de estudo durante o referido período e a qualidade ecológica da costa Portuguesa, segundo os termos definidos pela Comissão OSPAR, revelou melhorias notáveis após 2003 confirmando a eficácia do Regulamento (CE) N.º 782/2003. Não obstante, as populações de N. lapillus revelaram-se ainda amplamente afectadas por imposex, tendo sido detectadas emissões de TBT na água do mar ao longo da costa em 2006, apesar da restrição anteriormente referida. Estes inputs foram atribuídos principalmente aos navios que à data ainda circulavam com tintas AV com TBT aplicadas antes de 2003, uma vez que a sua utilização nas embarcações foi apenas proibida em 2008. Considerando que o Regulamento (CE) N.º 782/2003 constitui uma antecipação da proibição global da OMI que entrou em vigor em Setembro de 2008, prevê-se, por analogia, que haja uma rápida diminuição da poluição por TBT à escala mundial num futuro próximo. Na sequência desta previsão, é apresentada uma discussão teórica preliminar relativamente ás possíveis estratégias usadas por N. lapillus na recolonização de locais onde, no passado, as populações terão aparentemente sido extintas devido a níveis extremamente elevados de TBT. Estes locais são tipicamente zonas abrigadas junto de infra-estruturas portuárias, cuja recolonização por esta espécie será provavelmente muito lenta dada a mobilidade reduzida dos adultos e o ciclo de vida não apresentar fase larvar pelágica. Foram então equacionadas duas hipotéticas vias de recolonização de zonas abrigadas por espécimes provenientes de populações de costa aberta/exposta: a migração de adultos e/ou a dispersão de juvenis. No entanto, em ambos os casos, estaria implicada a transposição de um problema amplamente descrito na bibliografia: as populações de N. lapillus de costa aberta podem apresentar um fenótipo muito diferente das de zonas abrigadas, podendo inclusivamente variar no número de cromossomas. A recolonização pode portanto não ter sucesso pelo simples facto dos novos recrutas não estarem bem adaptados aos locais a recolonizar. Para analisar este problema, foram estudados tanto a forma da concha de espécimes de N. lapillus ao longo da costa Portuguesa como o respectivo número de cromossomas. Embora a forma da concha tenha revelado diferenças, de acordo com o grau de hidrodinamismo entre as populações de N. lapillus avaliadas, o cariótipo 2n = 26, típico de zonas expostas, foi registado em todos os locais amostrados. Por outro lado, foi também testada em laboratório a possível mortalidade de juvenis em dispersão no interior menos salino dos estuários. Foi então verificada a ocorrência de mortalidade elevada de juvenis expostos a salinidades baixas (=100% após 1 hora a salinidades ≤9 psu), o que também pode comprometer a recolonização de zonas estuarinas menos salinas por esta via. Mesmo assim, os juvenis mostraram um comportamento de flutuação à superfície da água em condições laboratoriais, que pode ser considerado um benefício específico na colonização de áreas mais internas dos estuários, se tal facto vier a ser confirmado em estudos de campo. As conclusões deste estudo contribuem certamente para a descrição do final da “história do TBT” dado que, uma vez controlados alguns factores determinantes no uso do imposex como biomarcador, a avaliação do declínio da poluição por estes compostos, agora esperado à escala global, se torna mais rigorosa.

Multifunctional nanoparticles for MR and fluorescence imaging

In the past few years a new generation of multifunctional nanoparticles (NPs) has been proposed for biomedical applications, whose structure is more complex than the structure of their predecessor monofunctional counterparts. The development of these novel NPs aims at enabling or improving the performance in imaging, diagnosis and therapeutic applications. The structure of such NPs comprises several components exhibiting various functionalities that enable the nanoparticles to perform multiple tasks simultaneously, such as active targeting of certain cells or compartmentalization, imaging and delivery of active drugs. This thesis presents two types of bimodal bio-imaging probes and describes their physical and chemical properties, namely their texture, structure, and 1H dynamics and relaxometry, in order to evaluate their potential as MRI contrast agents. The photoluminescence properties of these probes are studied, aiming at assessing their interest as optical contrast agents. These materials combine the properties of the trivalent lanthanide (Ln3+) complexes and nanoparticles, offering an excellent solution for bimodal imaging. The designed T1- type contrast agent are SiO2@APS/DTPA:Gd:Ln or SiO2@APS/PMN:Gd:Ln (Ln= Eu or Tb) systems, bearing the active magnetic center (Gd3+) and the optically-active ions (Eu3+ and Tb3+) on the surface of silica NPs. Concerning the relaxometry properties, moderate r1 increases and significant r2 increases are observed in the NPs presence, especially at high magnetic fields, due to susceptibility effects on r2. The Eu3+ ions reside in a single low-symmetry site, and the photoluminescence emission is not influenced by the simultaneous presence of Gd3+ and Eu3+. The presence of Tb3+, rather than Eu3+ ion, further increases r1 but decreases r2. The uptake of these NPs by living cells is fast and results in an intensity increase in the T1-weighted MRI images. The optical features of the NPs in cellular pellets are also studied and confirm the potential of these new nanoprobes as bimodal imaging agents. This thesis further reports on a T2 contrast agent consisting of core-shell NPs with a silica shell surrounding an iron oxide core. The thickness of this silica shell has a significant impact on the r2 and r2* relaxivities, and a tentative model is proposed to explain this finding. The cell viability and the mitochondrial dehydrogenase expression given by the microglial cells are also evaluated.

Effect of polyunsaturated fatty acids (PUFAs) on the proliferation and extracellular matrix mineralization and gene expression of gilthead seabream skeletal cell lines

The aquaculture industry aims at replacing significant amounts of marine fish oil by vegetable oils in fish diet. Dietary lipids have been shown to alter the fatty acid composition of bone compartments, which would impact the local production of factors controlling bone formation. Knowledge on the mechanisms underlying the nutritional regulation of bone metabolism is however scarce in fish. Two in vitro bone-derived cell systems developed from seabream (an important species for aquaculture in the Mediterranean region) vertebra, capable of in vitro mineralization and exhibiting prechondrocyte (VSa13) and pre-osteoblast (VSa16) phenotype, were used to assess the effect of certain polyunsaturated fatty acids (PUFAs; arachidonic (AA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids) on cell proliferation, extracellular matrix (ECM) mineralization and gene expression. While all PUFAs promoted morphological changes in both cell lines, VSa16 cell proliferation appeared to be stimulated by PUFAs in a dose dependent manner until 100M, whereas proliferation of VSa13 cells was impaired at concentrations above 10M. AA, EPA and DHA inhibited VSa13 ECM mineralization, alone and in combination, while VSa16 ECM mineralization was only inhibited by AA and EPA. DHA had the opposite effect, increasing mineralization almost by 2 fold. When EFAs were combined, DHA apparently compensated for the inhibitory effect of AA and EPA. Expression of marker genes for bone and lipid metabolisms has been investigated by qPCR and shown to be regulated in pre-osteoblasts exposed to individual PUFAs. Our results show that PUFAs are effectors of fish bone cell lines, altering cell morphology, proliferation and mineralization when added to culture medium. This work also demonstrates the suitability of our in vitro cell systems to get insights into mineralization-related effects of PUFAs in vivo and to evaluate the replacement of fish oils by vegetable oil sources in fish feeds.

How hydrogen peroxide and CXCL8 modulate neutrophil recruitment "in vivo"

Tese de doutoramento, Ciências Biomédicas (Biologia Celular e Molecular), Universidade de Lisboa, Faculdade de Medicina, 2014